Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Drug Metabolism and Disposition is Scopus-indexed (Q1, CiteScore 6.8), WoS SCIE. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 0090-9556Verify ISSN ↗1521-009XVerify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: About US$3,500 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 82 / 328 | 75th | Q1 |
| Pharmaceutical Science | 49 / 191 | 74th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1973–present, best quartile Q1, CiteScore 6.8.
Drug Metabolism and Disposition is Q1 in Pharmacology (rank 82 of 328) and Q2 in Pharmaceutical Science (rank 49 of 191), by CiteScore 2025.
Drug Metabolism and Disposition is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.8, which places it in quartile Q1 at the 75th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.054, quartile Q1, with an H-index of 202.
The publisher lists an article processing charge of about US$3,500 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Drug Metabolism and Disposition is published by Elsevier Inc. Its print ISSN is 0090-9556 and its online ISSN is 1521-009X.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Drug Metabolism and Disposition has an h-index of 206 and a 2-year mean of 3.07 citations per paper (OpenAlex). Its Scopus CiteScore is 6.8, quartile Q1. On 2-year citations it ranks #112 of 319 Scopus journals in Pharmacology.
Drug Metabolism and Disposition published 193 papers in 2025; its busiest recent year was 2018 with 238. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from United States (38.5%), China (20.2%) and Japan (13.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 5 retracted papers are recorded (0.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.